ComboTope Therapeutics

About ComboTope Therapeutics

ComboTope Therapeutics is a Denmark-based biotech company focused on antibody discovery and cancer therapeutics. The company promotes SMART-Phage, a proprietary antibody discovery platform designed to identify tumor-specific antibodies targeting aberrant glycosylation patterns, with broad applicability to cancer targets such as EGFR, VEGFR, HER2, and CD antigens. Its approach emphasizes tumor specificity and high affinity to develop antibody formats for cancer therapies, including ADCs, BsAbs, BiTEs, RIT, and CAR constructs. Led by co-founders with extensive experience in chemical biology and biotech startups, ComboTope aims to address multiple cancer indications across all cancers using tumor-associated epitopes. ©